共 95 条
[1]
Okamoto S(1962)Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of the fibrinolysis Keio J Med 11 105-115
[2]
Okamoto U(1966)The effect of a new potent antifibrinolytic agent, tranexamic acid J Jpn Obstet Gynecol Soc 13 158-167
[3]
Kobayashi T(1997)Enzyme-controlling medicines: introduction Semin Thromb Hemost 23 493-501
[4]
Sugiura J(2017)Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial Lancet 389 2105-2116
[5]
Okamoto S(2018)Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40138 bleeding patients Lancet 391 125-132
[6]
Hijikata-Okunomiya A(2007)Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation J Thromb Haemost 5 2113-2118
[7]
Wanaka K(2012)Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis Drugs 72 585-617
[8]
Okada Y(2012)Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors Can J Anaesth 59 6-13
[9]
Okamoto U(2016)Tranexamic acid-associated seizures: causes and treatment Ann Neurol 79 18-26
[10]
Gayet-Ageron A(2020)Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial Lancet 395 1927-1936